Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

794 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates.
Hong SH, Oh H, Park YW, Kwak HW, Oh EY, Park HJ, Kang KW, Kim G, Koo BS, Hwang EH, Baek SH, Park HJ, Lee YS, Bang YJ, Kim JY, Bae SH, Lee SJ, Seo KW, Kim H, Kwon T, Kim JH, Lee S, Kim E, Kim Y, Park JH, Park SI, Gonçalves M, Weon BM, Jeong H, Nam KT, Hwang KA, Kim J, Kim H, Lee SM, Hong JJ, Nam JH. Hong SH, et al. Among authors: park yw, park jh, park si, park hj. Sci Adv. 2021 May 28;7(22):eabg7156. doi: 10.1126/sciadv.abg7156. Print 2021 May. Sci Adv. 2021. PMID: 34049881 Free article.
Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial.
Song JY, Choi WS, Heo JY, Lee JS, Jung DS, Kim SW, Park KH, Eom JS, Jeong SJ, Lee J, Kwon KT, Choi HJ, Sohn JW, Kim YK, Noh JY, Kim WJ, Roman F, Ceregido MA, Solmi F, Philippot A, Walls AC, Carter L, Veesler D, King NP, Kim H, Ryu JH, Lee SJ, Park YW, Park HK, Cheong HJ. Song JY, et al. Among authors: park yw, park kh, park hk. EClinicalMedicine. 2022 Jul 22;51:101569. doi: 10.1016/j.eclinm.2022.101569. eCollection 2022 Sep. EClinicalMedicine. 2022. PMID: 35879941 Free PMC article.
Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques.
Jacob-Dolan C, Yu J, McMahan K, Giffin V, Chandrashekar A, Martinot AJ, Anioke T, Powers OC, Hall K, Hope D, Miller J, Hachmann NP, Chung B, Gardner S, Sellers D, Barrett J, Lewis MG, Andersen H, Kleanthous H, Seo KW, Lee SJ, Park YW, Kim H, Barouch DH. Jacob-Dolan C, et al. Among authors: park yw. NPJ Vaccines. 2023 Feb 23;8(1):23. doi: 10.1038/s41541-023-00622-0. NPJ Vaccines. 2023. PMID: 36823160 Free PMC article.
Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial.
Song JY, Choi WS, Heo JY, Kim EJ, Lee JS, Jung DS, Kim SW, Park KH, Eom JS, Jeong SJ, Lee J, Kwon KT, Choi HJ, Sohn JW, Kim YK, Yoo BW, Jang IJ, Capeding MZ, Roman F, Breuer T, Wysocki P, Carter L, Sahastrabuddhe S, Song M, D'Cor N, Kim H, Ryu JH, Lee SJ, Park YW, Cheong HJ; GBP510/AS03 study group. Song JY, et al. Among authors: park yw, park kh. EClinicalMedicine. 2023 Sep 7;64:102140. doi: 10.1016/j.eclinm.2023.102140. eCollection 2023 Oct. EClinicalMedicine. 2023. PMID: 37711219 Free PMC article.
Selective Enhancement of Viewing Angle Characteristics and Light Extraction Efficiency of Blue Thermally Activated Delayed Fluorescence Organic Light-Emitting Diodes through an Easily Tailorable Si3N4 Nanofiber Structure.
Park JY, Lee S, Bi JC, Lee JS, Hwang YH, Kang B, Seok J, Park S, Lim D, Park YW, Ju BK. Park JY, et al. Among authors: park yw. ACS Appl Mater Interfaces. 2024 May 14. doi: 10.1021/acsami.4c00240. Online ahead of print. ACS Appl Mater Interfaces. 2024. PMID: 38743438
794 results